ERBB2 and cancer: Other than hidden metastatic foci, this can be attributed to intratumoral heterogeneity, in which subpopulations of cancer cells differ genetically and phenotypically—i.e., have differential HER2 expression—from the primary tumor; this occurs in up to 40% of breast cancers [80,81].